Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.

In its first results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported Thursday weaker-than-expected fourth-quarter revenue, prompting its shares to fall in early morning trading despite quarterly profit beating projections.

Analysts expected earnings of $6.73 per share on $101.6 billion in revenue, according to the data firm FactSet. UnitedHealth Group Inc. operates the nation’s largest health insurer, UnitedHealthcare, which covers more than 49 million people in the United ...

UnitedHealth Group Inc. on Thursday posted higher earnings for the fourth quarter of 2024, but revenue fell short of Wall Street targets.

Healthcare giant's stock cuts more than 200 points off the Dow's price after a rare miss in quarterly revenue and as medical costs continue to rise Shares of UnitedHealth Group Inc. were took a ...

Andrew Witty, UnitedHealth Group’s CEO, defended the company ... $6.73 per share on $101.6 billion in earnings, according to FactSet. Though the flurry of social media criticism has moderated ...

Analysts expected earnings of $6.73 per share on $101.6 billion in revenue, according to the data firm FactSet. UnitedHealth Group Inc. operates the nation’s largest health insurer ...

UnitedHealth Group reported bottom-line earnings that surpassed estimates despite regulatory challenges impacting revenue.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Shares of Elevance Health were gaining after the health insurer turned in a strong quarter and increased its quarterly dividend. Elevance Health stock rose 4.4% to $408.03 in premarket trading Thursday.

Elevance Health Inc.'s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns after a big miss in the third quarter.

The updated tally extends the scope beyond what was previously described by company Chief Executive Andrew Witty.